Cancel

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

STATEMENT OF NEED Based on recent estimates, kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States. An estimated 65,300 new cases are reported each year and more than 14,000 people die of the disease. Renal cell carcinoma (RCC), which comprises nearly 90% of all kidney cancers, is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy. As a result of its often asymptomatic presentation,...
Penn State College of Medicine and i3 Health

Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy

STATEMENT OF NEED There are an estimated 13,240 new cases of cervical cancer in the United States each year, and 4,170 people die of the disease. Due to screening and heightened awareness, deaths have declined during the past few decades. However, the malignancy continues to be a global health concern and is considered an epidemic in parts of the world. A significant proportion of patients develop advanced disease, which is rarely curable with available therapies, and treatment is often lim...
Postgraduate Institute for Medicine and i3 Health

Nursing Strategies to Optimize Treatment Experiences in Hormone-Receptor Positive, HER2-Negative Metastatic Breast Cancer

STATEMENT OF NEED Breast cancer accounts for nearly 30% of cancer diagnoses among women in the United States, and is the second-leading cause of cancer death in this population. Although many women benefit from regular screening as well as earlier and improved treatment, approximately 10% present with metastatic disease, and 30% with no initial lymph node involvement eventually develop metastatic disease. Women with metastatic breast cancer (MBC) have a poorer prognosis than the overall pop...
USF Health and i3 Health

Current Challenges and New Opportunities in Follicular Lymphoma

STATEMENT OF NEED Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab...
Postgraduate Institute for Medicine and i3 Health

Current Trends in the Management of Castration-Resistant Prostate Cancer

STATEMENT OF NEED Prostate cancer is the most common tumor type in men in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Nonmetastatic castration-resistant prostate canc...
i3 Health

Challenges and Opportunities in Hodgkin Lymphoma

STATEMENT OF NEED Hodgkin lymphoma (HL) is a rare malignancy involving the lymph nodes and lymphatic system, with 8,500 new cases diagnosed and accounting for 1,050 deaths each year in the United States. In contrast with other cancers whose risk increases with age, the risk for HL increases in patients between 15 and 30 years of age, decreases during middle age, and is followed by another peak in adults older than 55. There are 2 main types of HL: classical HL, which accounts for 95% of cas...
i3 Health

Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies

STATEMENT OF NEED Although the clinical outcomes of patients with B-cell malignancies such as diffuse large B-cell lymphoma and B-cell acute lymphoblastic leukemia have improved during the past decade, many continue to develop relapsed or refractory disease, representing a significant cause of morbidity and mortality. CAR T-cell therapy has been shown to produce significant antitumor responses in these patients, for whom treatment options are limited. However, CAR T-cell therapy is associat...
i3 Health

Challenges and Opportunities in Metastatic Gastric Cancer

STATEMENT OF NEED Gastric cancer is the third leading cause of cancer-related death worldwide. In the US, an estimated 27,510 new cases of gastric cancer are diagnosed annually, and 11,140 people die of the disease. Despite advances in prevention, diagnosis, and treatment, due to the molecular heterogeneity of gastric cancer, prognosis remains poor. The 5-year survival rate for all stages is 31%, with only 5% of those diagnosed with distant-stage disease surviving longer than 5 years. Given...
i3 Health

Implementing New Data and Evolving Standards in Metastatic Triple-Negative Breast Cancer

STATEMENT OF NEED Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population. About 20% of patients have invasive triple-negative breast cancer (TNBC), which is defined as having estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) negativity. Whereas therapies targeting these receptors have demonstrated efficacy in other breast cancer ...
i3 Health

Optimizing Treatment Experiences in Castration-Resistant Prostate Cancer

STATEMENT OF NEED Prostate cancer is the most common tumor type in men in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Nonmetastatic castration-resistant prostate canc...
i3 Health

Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia

STATEMENT OF NEED Waldenstrom macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by lymphoplasmacytic bone marrow infiltration and the presence of serum monoclonal IgM. With an estimated 1,500 new cases reported in the United States annually, the malignancy accounts for 2% of non-Hodgkin lymphomas. Unfortunately, WM is considered incurable with available therapies. Patients with low- and intermediate-risk disease have 5-year survival rates of 87% and 68%, respective...
i3 Health

Innovations and New Practices in Internal Medicine 2019

The State of the Art in Internal Medicine This program provides a comprehensive update of the most important changes impacting Internal Medicine and guidance to incorporate these advances into everyday clinical practice to improve patient outcomes. Practical, Fast-Paced, Case-Based Education The educational experience is highly interactive and fast paced, and draws upon real-life cases. The course is designed and led by Harvard Medical School’s clinical faculty who are leaders in their re...
Harvard Medical School

20th Annual Dermatology in the Keys

There is an acute shortage of dermatologists in the United States. Dermatologists are shifting away from medical dermatology with many now focusing on cosmetic and oncologic procedures. Physician Assistants and Nurse Practitioners are rapidly becoming the medical dermatology providers as are primary care physicians. Medical and basic dermatologic surgery procedures have been identified as high priority in several needs assessment surveys for CME. Several mini-symposia, focusing on the diagn...
USF Health Professions Conferencing Corporation

Alzheimers Disease: Current and Emerging Treatments

Alzheimer's disease is the sixth leading cause of death in the United States, and the fifth leading cause of death for those 65 years and older. It is estimated that 5.7 million Americans of all ages are living with Alzheimer’s in 2018. By 2025, the number of people 65 and older affected by this disease is expected to reach 7.1 million. Without the development of medical breakthroughs, this number will increase to 13.8 million by 2050. There are many barriers and challenges to treatment of ...
MCPHS University

Management of Cancer Pain: Current Guidelines

STATEMENT OF NEED Cancer patients often experience a range of symptoms that negatively impact their quality of life. Among the most debilitating is pain. Despite efforts to increase awareness, cancer pain is still underdiagnosed and undertreated and patients do not obtain complete relief. Although numerous management guidelines for cancer pain have been developed, most health care practitioners do not universally apply them. As such, there remains a considerable gap in the management of pai...
i3 Health

Internal Medicine Comprehensive Review and Update 2019

This CME program from the leading clinical faculty of Harvard Medical School and Massachusetts General Hospital provides comprehensive instruction to ensure clinicians are current with the latest evidence and best practices for: • Cardiovascular Medicine • Pulmonary Medicine • Critical Care • Hematology and Oncology • Mind-Body Medicine • Infectious Diseases • Gastroenterology • Endocrinology • Rheumatology • Nephrology • Travel Medicine • Allergy and Immuno...
Harvard Medical School

New Insights into the Understanding of Thrombosis & Hemorrhage in Myeloproliferative Neoplasms: Improving Patient Outcomes

The myeloproliferative neoplasms (MPNs) are a group of hematologic malignancies that are associated with an extraordinary high incidence of thrombotic and hemorrhagic complications. In fact, these thrombotic events are the major cause of morbidity and mortality in patients with MPNs. Despite the importance of these events, our understanding of the pathobiology of thrombosis and hemorrhagic events in this group of disorders is understood only to limited extent. Thus, this meeting has been o...
Melton Medical Education, LLC

The Brigham Board Review in Hematology and Oncology

Get ready for the ABIM exam in Hematology-Oncology by studying this Brigham Board Review in Hematology and Oncology. Topics covered by the Brigham Board Review in Hematology and Oncology include: Molecular Genetics of Cancer, Cancer Drug Development, Hematopoietic Stem Cell Transplantation, Acute Leukemias, Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin's Lymphoma, B Cell Malignancies, Mesothelioma, Thyroid Cancer and dozens of others. After completing the Brigham Board Review in Hemat...
CMEInfo

The Brigham Board Review in Oncology: Brigham and Women's Hospital and Oakstone Board Review

Topics covered by The Brigham Board Review in Oncology include: Molecular Genetics of Cancer, Cancer Drug Development, Infections in Cancer Patients, Head and Neck Cancer, Thyroid Cancer, Pancreatic and Hepatobiliary Cancer, Renal and Bladder Cancer, Prostate Cancer and many others. Studying The Brigham Board Review in Oncology will better prepare you to: • Apply current/recommended Oncology guidelines in clinical practice • Perform differential diagnosis of complex Oncologic disorders...
CMEInfo

The Changing Landscape in Renal Cell and Bladder Cancers: Role of Immune Checkpoint Inhibitors

Immune checkpoint inhibitors offer hope for patients with either renal cell carcinoma or bladder cancer who cannot receive platinum-based chemotherapy, or who may not have responded or have stopped responding to traditional chemotherapy regimens. However, identifying the patients who stand to benefit the most from systemic immunotherapy and managing potential, associated adverse events are clinical challenges not well-addressed by existing guidelines. This virtual professorship program is led ...
ACHL

Rheumatology, Women's Health, and Gynecologic Oncology Eastern Caribbean Cruise

TBA
Continuing Education, Inc

Oncology Outlook 2019

Oncology Outlook
University of South Alabama Office of Continuing Medical Education

48th Annual Emery C. Miller Medical Symposium

This symposium is a review and update in primary care medicine intended for family physicians, internists and general practitioners. It also may be of value to physicians preparing for family medicine or internal medicine re-certification examinations. Lectures are case-based, and participants have the opportunity to actively participate in the sessions. The atmosphere is informal, and registrants are encouraged to participate in question-and-answer sessions. See brochure for lodging discount...
Northwest AHEC at Wake Forest School of Medicine

29th Annual Mayo Clinic Hematology/Oncology Reviews 2019

Mayo Clinic's 29th Annual Hematology/Oncology Reviews 2019 in Amelia Island, Florida is a comprehensive review of hematology/oncology that focuses on the application of new clinical and research advancements and developments over the preceding year. The most important clinical management questions in hematology/oncology will be addressed in highly interactive sessions. Attendees will leave with up-to-date, practical information which will have immediate clinical application. Attendees are enc...
Mayo Clinic

Intensive Review of Internal Medicine

The Acclaimed Clinical Update and Board Review With more than 120 interactive lectures, case discussions, and board preparation sessions, this CME program is the most comprehensive review of internal medicine offered by the clinical faculty of Harvard Medical School. One of the highest-rated Harvard Medical School CME courses, it sold out the last two years, so early registration is advised. It offers accelerated learning: ► For clinicians seeking a practical and comprehensive review ...
Harvard Medical School

Chemotherapy-Induced Nausea and Vomiting as a Barrier to Good Patient Outcomes

Oncology nursing professionals play a key role in the care of patients receiving chemotherapy. However, to do so, they require access to the most recent clinical information and guidance, the latest developments in CINV therapy, and expanded knowledge of CINV pathophysiology. In addition, oncology nursing professionals need continuing education focused on appropriate screening in order to better identify patients at risk of CINV before chemotherapy begins and develop the skills to undertake a ...
American Academy of CME

Management of Venous Thromboembolism in Ambulatory Patients With Cancer

STATEMENT OF NEED Venous thromboembolism (VTE) is a common and potentially life-threatening complication in patients with cancer. There are two main types of VTE: deep vein thrombosis (DVT) and pulmonary embolus (PE), which can cause right heart failure, cardiopulmonary collapse, and death (Ozaki & Bartholomew, 2012). Patients who develop PE require hospitalization, increased oxygen requirements, and the need for temporary and/or long-term anticoagulation. These complications, in turn, lead...
i3 Health

Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy

STATEMENT OF NEED Chemotherapy-induced peripheral neuropathy (CIPN) is a complication of cancer treatment that may impair quality of life and lead to treatment dose reductions or discontinuation in severe cases. In one study of 123 patients receiving taxane therapy for breast cancer, 17% required dose reductions because of CIPN (Bhatnagar et al, 2014). Whereas in some patients the symptoms of pain, numbness, and tingling improve with time, in others, there is progression with permanent nerv...
i3 Health

Management of Venous Thromboembolism in Hospitalized Patients With Cancer

STATEMENT OF NEED Venous thromboembolism (VTE), which consists primarily of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death (NCCN, 2016). The mainstay of treatment is anticoagulation; however, since cancer patients with VTE have higher rates of bleeding complications, VTE risk assessment is essential to determine which patients will benefit f...
i3 Health

Crucial Conversations in Oncology Nursing: Management Considerations for the AML Patient

The landscape of AML treatment is evolving and newer targeted agents may improve outcomes for selected subgroups of patients. Oncology nursing professionals provide disease and treatment information, manage adverse effects, and offer emotional support. Knowledge of the key management issues for patients with AML is critical in fulfilling this role. Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and po...
American Academy of CME

Targeting EGFR Mutation-positive NSCLC: Critical Advances in Care

New developments in the role of mutations in the epidermal growth factor receptor (EGFR) gene are transforming the understanding of how NSCLC progresses as a disease. This insight has enabled NSCLC to evolve from an untreatable disease to one where a number of novel therapeutic options are available, and individualized treatment regimens are now offered to optimize care. This digital flipbook includes pertinent data and video insights into new and practice-changing therapy in the setting of...
ACHL

4th Annual Cutaneous Oncology Symposium 2019

This two-day course focuses on ten controversial topics in cutaneous oncology covering the fields of dermatology, surgical oncology, radiation oncology and medical oncology. The goal is to discuss the available evidence of these topics to assist in making the most informed decisions. Current and new advances in therapeutic treatments for both melanoma and non-melanoma skin cancers, especially, basal cell, squamous cell and Merkel cell carcinoma will be highlighted with the presentations an...
Mayo Clinic

Through Your Patient’s Eyes™ - Comprehensive Relief from Cancer Pain: Expanding the Conversation on Opioid-Induced Constipation

Despite a growing number of specific treatment options, many patients with cancer pain still suffer from opioid-induced constipation (OIC).1-3 Open communication among patients, caregivers, and treating clinicians is essential to determine the severity and psychosocial consequences of OIC.1-4 Patients with cancer pain and their proxies, however, are often reluctant to discuss opioid-related gastrointestinal symptoms and effects on quality of life. To address this barrier, clinicians should pro...
Integritas Communications

OCN® Exam Review - Miami

This program is designed for oncology nurses seeking a general oncology review in preparation for the ONCC® OCN Exam. We will focus on the following categories from the 2016 OCN blueprint: cancer epidemiology, health promotion and cancer screening, scientific basis for practice, treatment modalities, symptom management, psychosocial care, oncologic emergencies, palliative/end-of-life care and survivorship. This is not meant to be an introductory course, but rather a comprehensive review of ba...
MED-ED

Update in Clinical Cardiology

The Comprehensive 2019 Update for Clinical Cardiology Evaluation • Treatment • Patient Care • Procedures • Challenging Cases This CME program provides a comprehensive review of state-of-the-art practices to diagnose and treat patients with cardiovascular conditions. Led by the leading clinical faculty of Harvard Medical School and the Massachusetts General Hospital (MGH) Corrigan Minehan Heart Center, Update in Clinical Cardiology ensures attendees are current with recent advances in...
Harvard Medical School

12th International Congress on Myeloproliferative Neoplasms

Since its inception 18 years ago, the International Congress on Myeloproliferative Neoplasms has provided a forum for the interaction of practicing hematologists, oncologists, translational scientists, and other healthcare professionals with experts from both the US and Europe in the myeloproliferative neoplasms, including chronic myeloid leukemia, the hyper-eosinophilic syndromes and mastocytosis. This year’s CME-accredited program will feature the latest information on the pathophysiology ...
Melton Medical Education, LLC

TKI Therapy in CML: Emerging Treatments, Ensuring Safety

This Virtual Practice summarizes advances in tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) in the context of disease- and patient-specific characteristics; reviews the most effective methods for monitoring early response and long-term therapeutic outcomes; assesses the milestones and mutational analyses to identify when a change in TKI therapy is needed; compares toxicity profiles of the currently available TKI agents; and examines how toxicity could interact with...
Albert Einstein College of Medicine and RedMedEd

Neurology 2019

Comprehensive Updates and State-of-the-Art Practices for Outpatient and Inpatient Neurology This highly rated Harvard Medical School CME program, which has sold out the last 2 years, provides a comprehensive, evidence-based review of state-of-the-art practices for outpatient and inpatient neurology. Education covers the latest guidelines, clinical strategies, use of imaging and new diagnostic tools (including genetic tests), and recent advances for treatment for a wide array of neurological d...
Harvard Medical School

Nursing Management of Cancer Treatment-Induced Cardiotoxicity

STATEMENT OF NEED Several studies reveal that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. Adverse cardiac effects may occur immediately after cessation of therapy or, in some cases, years after the therapy has been discontinued. Often the cardiotoxicity presents in subtle ways, and a lack of awareness results in high morbidity and mortality. It is important for oncology nurses to be aware of current advances in the ...
i3 Health

Radiation Oncology - A Comprehensive Review: Oakstone Clinical Update

Topics covered in Radiation Oncology include: New Modalities, Central Nervous System Tumors, Head and Neck Tumors, Thoracic Tumors, Upper Gastrointestinal Tumors, Liver Stereotactic Body Radiation Therapy, Soft Tissue Sarcomas. Lymphomas and many others. After studying Radiation Oncology, you will be better able to: • Define the initial clinical evaluation of a patient - using physical exam, history, relevant diagnostic studies, and communication with referring and other physicians involve...
CMEInfo

Board Vitals Hematology and Oncology Board Review Question Bank

The Hematology and Oncology Board Review Question Bank features over 800 Hematology and Oncology questions. The Hematology Oncology exam study guide features: • Over 800 review questions and answers • The leading digital question bank for Oncology Board Prep • Percent correct provided on most questions to compare against the national average • Timed mode available to simulate exam conditions • Access from any computer or smartphone! • Also available: CME Redemption
Board Vitals

Analysis of Recently Published Acute Lymphoblastic Leukemia Articles /

In this CME activity Elias Jabbour, MD, reviews some of the recent clinical developments in advanced acute lymphoblastic leukemia. We invite you to learn more about the current and emerging standards of care, as well as safety and efficacy data from the select clinical trials, in patients with acute lymphoblastic leukemia. CONTENT AREAS • CD19-positive ALL • A bispecific T-cell engager antibody • Philadelphia chromosome-positive ALL • Tyrosine kinase inhibitor • Complete rem...
Annenberg Center for Health Sciences at Eisenhower

The Evolution of Multiple Myeloma Patient Management: Managing Today, Preparing for Tomorrow

The clinical multiple myeloma arena has undergone significant advances in diagnosis and prognosis, minimal residual disease monitoring, and supportive care. This expansion brings renewed hope to patients, but it presents new challenges for the clinicians charged with their care. Some patients enjoy many years in clinical remission, whereas for others survival is no more than 2 or 3 years. This reflects the heterogeneity of myeloma and underscores the inappropriateness of a one-size-fits-all ma...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Geriatric Massage - Online CE Class for Massage Therapists and all interested parties

Geriatric massage is a form of massage designed to meet the specific needs of the elderly population. Information contained in this course includes: Demographics of Aging, Geriatric Massage Techniques, Benefits of Geriatric Massage, Precautions and Contraindications, Anatomical Effects of Aging, Cardiovascular Effects of Aging, Metabolic Effects of Aging, Dementia, Fibromyalgia, Hospice Massage, Geriatric Massage in a Home Environment, Oncology Massage, Geriatric Massage for Wheelchair Bound C...
Ariana Institute

Preventive Health for Adults: Current Screening Guidelines for Heart Disease and Cancer

To achieve the Triple Aim of Healthcare (better care, better health, and lower costs), it is critical that primary care providers be aware of appropriate means of disease prevention and detection, particularly for heart disease and cancer, the two leading causes of death in the US. This session is specially designed for internists, family practitioners, and other primary care clinicians. After completing this activity, participants will be better able to implement the latest evidence-based...
Rockpointe

Preventing and Managing Cytomegalovirus in High-Risk Hematopoietic Cell Transplantation Patients: Expert Answers to Frequently Asked Questions

Why has prophylaxis been used infrequently in the past compared with preemptive treatment strategies for post-HCT CMV prevention? Until recently, preemptive management was the most common strategy for the management of post-HCT CMV infection in most cancer centers. However, this approach has many shortcomings, including a lack of consensus on the CMV DNA thresholds, and... Review this CME-certified FAQ written by Drs. Roy Chemaly and Genovefa Papanicolaou to learn more.
Postgraduate Institute for Medicine

Nursing Management of Bone Health in Patients With Cancer

STATEMENT OF NEED Many tumors, such as prostate, breast, lung, and multiple myeloma, affect bone health. Once cancer spreads to the skeletal system, the risk for pain, fractures, hypercalcemia, and nerve compression increases considerably. Several studies have shown that the use of antiresorptive agents such as bisphosphonates and monoclonal antibodies can reduce the morbidity of skeletal complications in patients with cancer and significantly improve quality of life. Combined with preventi...
i3 Health

Interactive Case Challenge: Preventing and Managing Cytomegalovirus in High-Risk Hematopoietic Cell Transplantation Patients

Explore important considerations in CMV prophylaxis and treatment in patients who have undergone hematopoietic cell transplantation.
Postgraduate Institute for Medicine

Clinical Updates in Chronic Myeloid Leukemia: New Understandings in Disease Diagnosis, Monitoring and Personalized Therapeutic Regimens Utilizing Tyrosine Kinase Inhibitors

Advance your understanding on how to better diagnose, treat, and monitor CML. Expert faculty from MD Anderson recently gave a series of lectures across the country on the latest research and treatment regimen recommendations in CML. Highlighting key takeaways from this meeting series, faculty review the role of ABL tyrosine kinase inhibitor (TKI) agents in advancing treatment and delivering up-to-date care as well as discuss safety and tolerability of various approved TKIs in CML. They examine...
ACHL

Myeloma Masters: The Ultimate Myeloma Patient Care Quiz Show

Keeping pace with the rapid advances in multiple myeloma patient care presents a considerable challenge to health care providers—and potentially leaves patients at a loss to understand their disease and the options available for managing it. In the format of an entertaining interactive game (think Who Wants to Be a Millionaire), this activity tests players’ knowledge of current and emerging myeloma patient care best practices. Along the way—using a range of multimedia prompts and hints...
Rush University Medical Center

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.